Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells.
Spiegel HM, Ogg GS, DeFalcon E, Sheehy ME, Monard S, Haslett PA, Gillespie G, Donahoe SM, Pollack H, Borkowsky W, McMichael AJ, Nixon DF. Spiegel HM, et al. Among authors: nixon df. J Virol. 2000 Jan;74(2):1018-22. doi: 10.1128/jvi.74.2.1018-1022.2000. J Virol. 2000. PMID: 10623767 Free PMC article.
The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children.
Spiegel HM, Chandwani R, Sheehy ME, Dobroszycki J, Fennelly G, Wiznia A, Radding J, Rigaud M, Pollack H, Borkowsky W, Rosenberg M, Nixon DF. Spiegel HM, et al. Among authors: nixon df. J Infect Dis. 2000 Jul;182(1):88-95. doi: 10.1086/315639. Epub 2000 Jun 27. J Infect Dis. 2000. PMID: 10882585 Clinical Trial.
Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption.
Papasavvas E, Ortiz GM, Gross R, Sun J, Moore EC, Heymann JJ, Moonis M, Sandberg JK, Drohan LA, Gallagher B, Shull J, Nixon DF, Kostman JR, Montaner LJ. Papasavvas E, et al. Among authors: nixon df. J Infect Dis. 2000 Sep;182(3):766-75. doi: 10.1086/315748. Epub 2000 Aug 17. J Infect Dis. 2000. PMID: 10950770 Clinical Trial.
Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19.
Tolfvenstam T, Oxenius A, Price DA, Shacklett BL, Spiegel HM, Hedman K, Norbeck O, Levi M, Olsen K, Kantzanou M, Nixon DF, Broliden K, Klenerman P. Tolfvenstam T, et al. Among authors: nixon df. J Virol. 2001 Jan;75(1):540-3. doi: 10.1128/JVI.75.1.540-543.2001. J Virol. 2001. PMID: 11119624 Free PMC article.
320 results